Survival AnalysisSurvival RateCell SurvivalKaplan-Meier EstimatePrognosisDisease-Free SurvivalProportional Hazards ModelsRetrospective StudiesTreatment OutcomeSurvivalTime FactorsFollow-Up StudiesNeoplasm StagingGraft SurvivalMultivariate AnalysisRisk FactorsCohort StudiesTumor Markers, BiologicalProspective StudiesImmunohistochemistryBreast NeoplasmsPredictive Value of TestsAge FactorsLung NeoplasmsNeoplasm Recurrence, LocalDisease ProgressionRegistriesCombined Modality TherapyLymphatic MetastasisAdenocarcinomaLife TablesAntineoplastic Combined Chemotherapy ProtocolsRecurrenceRisk AssessmentIncidenceBrain NeoplasmsCarcinoma, Squamous CellTissue Array AnalysisLiver NeoplasmsChemotherapy, AdjuvantCarcinomaProsthesis FailureColorectal NeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell LungGene Expression Regulation, NeoplasticNeoplasm GradingApoptosisRegression AnalysisReoperationAntineoplastic AgentsNeoplasm InvasivenessStomach NeoplasmsLongitudinal StudiesSex FactorsOvarian NeoplasmsModels, StatisticalUnited StatesNeoplasmsCell Line, TumorAnalysis of VarianceChi-Square DistributionSEER ProgramBiostatisticsLongevityCause of DeathCarcinoma, HepatocellularProbabilityGene Expression ProfilingKidney Failure, ChronicKi-67 AntigenAge of OnsetGlioblastomaRadiotherapy, AdjuvantSeverity of Illness IndexRiskMelanomaSignal TransductionMutationPostoperative ComplicationsActuarial AnalysisCannibalismCell ProliferationCisplatinEsophageal Neoplasms